Frankfurt
25.02.25
08:07 Uhr
0,001 Euro
-0,011
-95,65 %
-95,65 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Polarean Imaging PLC - Virtual Investor Day | - | RNS | ||
| 03.02. | Polarean Imaging shares jump as inks first distribution deal in Taiwan | - | Alliance News | ||
| 03.02. | Polarean Imaging PLC - Taiwanese distributor agreement with Sumtage | - | RNS | ||
| 30.01. | Polarean Imaging PLC - Key patent in China secured | - | RNS | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 28.01. | Polarean Imaging PLC - Collaboration to Advance Lung Imaging Innovation | - | RNS | ||
| 21.11.24 | IN BRIEF: Polarean Imaging gets FDA approval for MRI chest coil | 4 | Alliance News | ||
| 21.11.24 | Polarean's Xenoview 3T gets new FDA clearance | 1 | Sharecast | ||
| 21.11.24 | Polarean: FDA clears XENOVIEW 3T Chest Coil in GE HealthCare MRI Systems | 5 | GlobeNewswire (USA) | ||
| 21.11.24 | Polarean Imaging PLC - FDA clears Chest Coil in GE HealthCare MRI Systems | 2 | RNS | ||
| 25.09.24 | Polarean Imaging PLC - Virtual investor day | 1 | RNS | ||
| 04.09.24 | Polarean Imaging PLC - Half-year Report | 1 | RNS | ||
| 03.09.24 | Polarean: Appointment of Alan Huang, PhD, as Vice President of Sales | 1 | GlobeNewswire (USA) | ||
| 03.09.24 | Polarean Imaging PLC - Appointment of Vice President of Sales | - | RNS | ||
| 28.08.24 | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 244 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen | |
| 23.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 23.05.2024 | 811 | Xetra Newsboard | Das Instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY wird ex Kapitalmassnahme gehandelt am 23.05.2024 The instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY is traded ex capital adjustment... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 86,00 | -0,20 % | Medtronic Granted FDA Approval For BrainSense Adaptive Deep Brain Stimulation System For Parkinson's | DUBLIN (dpa-AFX) - Medtronic plc (MDT), healthcare technology firm, announced Monday the U.S. Food and Drug Administration (FDA) approval of BrainSense Adaptive deep brain stimulation (aDBS)... ► Artikel lesen | |
| HCA HEALTHCARE | 309,10 | +1,21 % | HCA Healthcare Stock: Is Wall Street Bullish or Bearish? | ||
| AMEDISYS | 86,00 | +1,18 % | Amedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or later | ||
| LANTHEUS | 75,08 | -0,48 % | Evergreen Theragnostics, Inc.: Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader | Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilitiesAdds OCTEVY, a registrational-stage diagnostic... ► Artikel lesen | |
| ENVISTA | 20,000 | +0,50 % | Envista: DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences | The global leader in dental imaging technologies will showcase the latest innovations added to its digital ecosystem - a suite of tools and software designed to connect the entire digital workflow from... ► Artikel lesen | |
| CAREDX | 20,330 | -0,49 % | CareDx, Inc.: CareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA bei der Erkennung von Abstoßungsreaktionen bei Organtransplantationspatienten äußerst genau ist | AlloSeq cfDNA entspricht der Leistung des bewährten AlloSure-Tests CareDx bringt mit AlloSeq cfDNA ein innovatives nicht-invasives Transplantationsmonitoring für Patienten auf internationaler... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Second Quarter 2025 Results | Reports 23 Percent Increase in ARR to $19.1 Million and 61 Net New Platform Deployments HENDERSON, Nev., Feb. 13, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading... ► Artikel lesen | |
| GT BIOPHARMA | 2,240 | +6,67 % | GT Biopharma kündigt Optionsausübung an und plant neue Emission | ||
| CARMAT | 0,941 | -1,47 % | CARMAT: Aeson total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation | Up to 25% of advanced heart failure patients suffer from pulmonary hypertension
Aeson® could potentially become a standard treatment for these thousands of patients, both as a bridge-to-transplant... ► Artikel lesen | |
| CHEMOMETEC | 79,70 | -0,56 % | Chemometec A/S: Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings | ANNOUNCEMENT NO. 2875 February 2025 Solid H1 performance driven by growth in both revenue and earnings Martin Helbo Behrens, CEO: The growth continued in the second quarter of 2024/25, and revenue... ► Artikel lesen | |
| HAMILTON THORNE | 1,490 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
| PROMIMIC | 2,030 | -7,31 % | Karolinska Development AB (publ): Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface | STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 10,750 | 0,00 % | Devyser Diagnostics AB: Devyser secures a major SEK 16.8M tender in Italy with 30% growth | Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for the supply of its comprehensive next-generation sequencing (NGS) tests for critical genetic markers.... ► Artikel lesen | |
| ARRAIL GROUP | 0,304 | -1,30 % | ARRAIL GROUP (06639): 2024/2025 INTERIM REPORT | ||
| SIEMENS HEALTHINEERS | 54,22 | -0,51 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Siemens Healthineers, Kerry Group, Capgemini und BHP | © Foto: Daniel Karmann/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 00:30... ► Artikel lesen |
POLAREAN IMAGING PLC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -95,65 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.
